The latest update is out from Praxis Precision Medicines (PRAX).
Praxis Medicines has released an updated corporate presentation for stakeholders, which can now be accessed on the “Investors + Media” section of their website. The company emphasizes that the content provided, including the presentation, is for informational purposes and isn’t considered filed under securities laws, nor is it incorporated by reference into any legal filings, except where explicitly stated.
See more insights into PRAX stock on TipRanks’ Stock Analysis page.
